Patents by Inventor Heiko Herwald

Heiko Herwald has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • DIAGNOSTIC METHOD FOR URINARY TRACT INFECTION
    Publication number: 20190079104
    Abstract: It has been demonstrated that the urinary level of HBP increases in individuals that have a urinary tract infection. Accordingly, the urinary level of HBP in an individual can be used to determine whether or not an individual has a urinary tract infection.
    Type: Application
    Filed: September 21, 2018
    Publication date: March 14, 2019
    Inventors: Lars BJÖRCK, Bertil CHRISTENSSON, Heiko HERWALD, Adam LINDER, Per AKESSON
  • Diagnostic method for urinary tract infection
    Patent number: 10126312
    Abstract: It has been demonstrated that the urinary level of HBP increases in individuals that have a urinary tract infection. Accordingly, the urinary level of HBP in an individual can be used to determine whether or not an individual has a urinary tract infection.
    Type: Grant
    Filed: May 12, 2016
    Date of Patent: November 13, 2018
    Assignee: Hansa Medical AB
    Inventors: Lars Björck, Bertil Christensson, Heiko Herwald, Adam Linder, Per Åkesson
  • Diagnostic method
    Patent number: 9784741
    Abstract: It has been demonstrated that the level of HBP increases in individuals that subsequently develop severe sepsis. Accordingly, the level of HBP, HBP/WBC ratio or HBP/NC ratio in an individual can be used to determine whether or not an individual is at risk of developing severe sepsis.
    Type: Grant
    Filed: December 2, 2013
    Date of Patent: October 10, 2017
    Assignee: Hansa Medical AB
    Inventors: Lars Björck, Bertil Christensson, Heiko Herwald, Adam Linder, Per Åkesson
  • Diagnostic method for bacterial meningitis
    Patent number: 9759720
    Abstract: It has been demonstrated that the level of HBP increases in individuals that have bacterial meningitis. Accordingly, the level of HBP in an individual can be used to determine whether or not an individual has bacterial meningitis.
    Type: Grant
    Filed: September 23, 2011
    Date of Patent: September 12, 2017
    Assignee: Hansa Medical AB
    Inventors: Lars Björck, Bertil Christensson, Heiko Herwald, Adam Linder, Per Åkesson
  • DIAGNOSTIC METHOD FOR URINARY TRACT INFECTION
    Publication number: 20160252529
    Abstract: It has been demonstrated that the urinary level of HBP increases in individuals that have a urinary tract infection. Accordingly, the urinary level of HBP in an individual can be used to determine whether or not an individual has a urinary tract infection.
    Type: Application
    Filed: May 12, 2016
    Publication date: September 1, 2016
    Inventors: Lars BJÖRCK, Bertil Christensson, Heiko Herwald, Adam Linder, Per Åkesson
  • DIAGNOSTIC METHOD
    Publication number: 20140187503
    Abstract: It has been demonstrated that the level of HBP increases in individuals that subsequently develop severe sepsis. Accordingly, the level of HBP, HBP/WBC ratio or HBP/NC ratio in an individual can be used to determine whether or not an individual is at risk of developing severe sepsis.
    Type: Application
    Filed: December 2, 2013
    Publication date: July 3, 2014
    Applicant: Hansa Medical AB
    Inventors: Lars Björck, Bertil Christensson, Heiko Herwald, Adam Linder, Per Åkesson
  • DIAGNOSTIC METHOD FOR BACTERIAL MENINGITIS
    Publication number: 20140080754
    Abstract: It has been demonstrated that the level of HBP increases in individuals that have bacterial meningitis. Accordingly, the level of HBP in an individual can be used to determine whether or not an individual has bacterial meningitis.
    Type: Application
    Filed: September 23, 2011
    Publication date: March 20, 2014
    Applicant: HANSA MEDICAL AB
    Inventors: Lars Björck, Bertil Christensson, Adam Linder, Heiko Herwald, Per Åkesson
  • DIAGNOSTIC METHOD FOR URINARY TRACT INFECTION
    Publication number: 20140080925
    Abstract: It has been demonstrated that the urinary level of HBP increases in individuals that have a urinary tract infection. Accordingly, the urinary level of HBP in an individual can be used to determine whether or not an individual has a urinary tract infection.
    Type: Application
    Filed: February 7, 2012
    Publication date: March 20, 2014
    Applicant: Hansa Medical AB
    Inventors: Lars Björck, Bertil Christensson, Heiko Herwald, Adam Linder, Per Åkesson
  • DIAGNOSTIC METHOD
    Publication number: 20130252347
    Abstract: It has been demonstrated that the level of HBP increases in individuals that subsequently develop severe sepsis. Accordingly, the level of HBP, HBP/WBC ratio or HBP/NC ratio in an individual can be used to determine whether or not an individual is at risk of developing severe sepsis.
    Type: Application
    Filed: March 12, 2013
    Publication date: September 26, 2013
    Applicant: Hansa Medical AB
    Inventors: Lars Bjorck, Bertil Christensson, Heiko Herwald, Adam Linder, Per Akesson
  • Diagnostic method
    Patent number: 8518648
    Abstract: It has been demonstrated that the level of HBP increases in individuals that subsequently develop severe sepsis. Accordingly, the level of HBP, HBP/WBC ratio or HBP/NC ratio in an individual can be used to determine whether or not an individual is at risk of developing severe sepsis.
    Type: Grant
    Filed: June 12, 2008
    Date of Patent: August 27, 2013
    Assignee: Hansa Medical AB
    Inventors: Lars Björck, Bertil Christensson, Heiko Herwald, Adam Linder, Per Åkesson
  • ANCESTRAL SERINE PROTEASE COAGULATION CASCADE EXERTS A NOVEL FUNCTION IN EARLY IMMUNE DEFENSE
    Publication number: 20130177547
    Abstract: The present invention relates to blood coagulation factor XIII (FXIII) for treatment and/or prevention of an infection by a microorganism and/or the symptoms associated with said infection, a pharmaceutical composition comprising a pharmaceutically effective amount of said FXIII, a method for the manufacture of a medicament comprising a pharmaceutically effective amount of said FXIII, and a method of treatment comprising administering to a patient in need a pharmaceutically effective amount of said FXIII.
    Type: Application
    Filed: July 20, 2011
    Publication date: July 11, 2013
    Applicants: HANSA MEDICAL AB, CSL BEHRING GMBH
    Inventors: Heiko Herwald, Ulrich Theopold, Torsten Loof, Matthias Mörgelin, Gerhard Dickneite
  • DIAGNOSTIC METHOD
    Publication number: 20100305185
    Abstract: It has been demonstrated that the level of HBP increases in individuals that subsequently develop severe sepsis. Accordingly, the level of HBP, HBP/WBC ratio or HBP/NC ratio in an individual can be used to determine whether or not an individual is at risk of developing severe sepsis.
    Type: Application
    Filed: June 12, 2008
    Publication date: December 2, 2010
    Inventors: Lars Björck, Bertil Christensson, Heiko Herwald, Adam Linder, Per Åkesson
  • Method for identifying an anti- streptococcal agent and its use for treating streptococcal infections
    Publication number: 20070172471
    Abstract: A method for identifying an anti-streptococcal agent, comprises: (a) providing, as a first component, an isolated streptococcal M protein or a functional variant thereof; (b) providing, as a second component, isolated fibrinogen or a functional variant thereof; (b) providing, as a third component, an isolated ?2 integrin or a functional variant thereof; (d) contacting said components with a test substance under conditions that would permit the components to interact in the absence of the test substance; and (e) determining whether the test substance inhibits the interaction between the components; thereby to determine whether a test substance is an anti-streptococcal agent.
    Type: Application
    Filed: April 23, 2004
    Publication date: July 26, 2007
    Inventors: Lars Bjorck, Heiko Herwald, Matthias Morgelin, Wayne Russell, Anna Norrby-Teglund, Lennart Lindbom, Ulla Sollenberg, Henning Cramer, Hans Flodgaard
  • Treatment of bacterial infections
    Patent number: 6242210
    Abstract: An assay for compounds useful in the treatment of a bacterial induced coagulation disorder has the following steps: a) incubating a plasma sample with a strain of bacteria; b) adding a compound to be assayed to the plasma sample before, during or after step (a); c) conducting an activated partial thromboplastin time test; d) determining the clotting time.
    Type: Grant
    Filed: February 26, 1999
    Date of Patent: June 5, 2001
    Assignee: Actinova Limited
    Inventors: Lars Björck, Ulf Sjörbring, Abdelhakim Ben Nasr, Arne Olsén, Heiko Herwald, Werner Müller-Esterl, Eva Mattsson
  • Use of kinin antagonists for preparing a pharmaceutical composition for treating bacterial infections
    Patent number: 6221845
    Abstract: Kinin antagonists, especially bradykinin antagonists, can be used for treating bacterial infections, in particular infections caused by bacteria belonging to the genera Streptococcus, Escherichia, Salmonella, Staphylococcus, Klebsiella, Moracella, Haemophilus and Yersinia.
    Type: Grant
    Filed: June 25, 1999
    Date of Patent: April 24, 2001
    Assignee: Actinova Limited
    Inventors: Lars Björck, Ulf Sjöbring, Abdelhakim Ben Nasr, Arne Olsén, Heiko Herwald, Werner Müller-Esterl